NCT05927818Recruiting
Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Efficacy of Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer
Source: ClinicalTrials.gov · Last updated 25 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing it to the results obtained from systematic lymphadenectomy, each performed in participants with a suspicious adnexal mass for early-stage ovarian cancer.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 9 Jun 2023
- Start date
- 15 Apr 2023
- Primary completion date
- 15 Oct 2025
- Lead sponsor
- Istanbul University
- Diseases
- Ovarian cancer
- NCT number
- NCT05927818
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 15 Apr 2023 to the primary completion date, 15 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Medical or surgical contraindications for surgical comprehensive staging.
Other illness
- Ovarian mass with low probability for early stage ovarian cancer.
- Metastatic cancers or double primary cancers (metachronous) of ovary
- Recurrent ovarian cancer
- Preoperative or intraoperative finding of advanced ovarian cancer (FİGO stage III and IV)
- Neoadjuvant ovarian cancer
Other
- \-
Who the study is looking for
- Must have a suspicious adnexal mass for early stage ovarian cancer
- Must be medically and surgically fit enough to perform SLNB and complete the systematic lymphadenectomy.
- \-
Age in the registry: 18 years to 90 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.